NCT02714062View on ClinicalTrials.gov

A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese Adolescents

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

November 30, 2016

Conditions
Pediatric ObesityChildhood Obesity
Interventions
DRUG

Placebo

po once daily

DRUG

VI-0521 Mid Dose

po once daily

DRUG

VI-0521 Top Dose

po once daily

Trial Locations (4)

29403

Research Facility, Charleston

45229

Research Facility, Cincinnati

70072

Research Facility, Marrero

70808

Research Facility, Baton Rouge

All Listed Sponsors
lead

VIVUS LLC

INDUSTRY

NCT02714062 - A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese Adolescents | Biotech Hunter | Biotech Hunter